Literature DB >> 3485195

Calcium and vitamin D metabolism in children with nephrotic syndrome.

M Freundlich, J J Bourgoignie, G Zilleruelo, C Abitbol, J M Canterbury, J Strauss.   

Abstract

Although abnormalities of calcium and vitamin D metabolism are recognized in children with nephrotic syndrome, longitudinal observations are not available in these patients during periods of relapse and remission. We report observations in 58 children (mean age 10.1 years) with nephrotic syndrome and normal glomerular filtration rate. Hypocalcemia, modest hyperparathyroidism, and strikingly low calcidiol levels were identified during episodes of relapse. Most alterations were transient, and normalized on remission. The plasma concentration of calcitriol, the most active metabolite of vitamin D, was found to be normal in both relapse and remission. In the presence of hypocalcemia and hyperparathyroidism, however, normal plasma calcitriol levels in relapse may be inappropriately low and reflect a state of relative deficiency. Concurrent glucocorticoid therapy did not modify the results. A corollary of our observations is that children with relapsing or protracted nephrotic syndrome are at risk of developing metabolic bone disease, even without impairment of glomerular filtration rate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485195     DOI: 10.1016/s0022-3476(86)80877-0

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  15 in total

1.  Vitamin D metabolites in childhood nephrotic syndrome.

Authors:  U S Alon
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

2.  Free vitamin D levels in steroid-sensitive nephrotic syndrome and healthy controls.

Authors:  Sushmita Banerjee; Surupa Basu; Shakil Akhtar; Rajiv Sinha; Ananda Sen; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

3.  Disease activity, proteinuria, and vitamin D status in children with systemic lupus erythematosus and juvenile dermatomyositis.

Authors:  Angela Byun Robinson; Myrtle Thierry-Palmer; Keisha L Gibson; Consuelo Egla Rabinovich
Journal:  J Pediatr       Date:  2011-09-15       Impact factor: 4.406

4.  Hearing status in children with frequently relapsing and steroid resistant nephrotic syndrome.

Authors:  Abhijeet Saha; Vivek Gupta; Kanika Kapoor; N K Dubey; Priti Lal; T S Sidhu; V V Batra; A D Upadhyay
Journal:  Pediatr Nephrol       Date:  2012-12-12       Impact factor: 3.714

Review 5.  Bone Health in Glomerular Kidney Disease.

Authors:  Dorey A Glenn; Michelle R Denburg
Journal:  Curr Osteoporos Rep       Date:  2019-12       Impact factor: 5.096

6.  Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes.

Authors:  Debika Nandi-Munshi; Maryam Afkarian; Kathryn B Whitlock; Jamie L Crandell; Ronny A Bell; Ralph D'Agostino; Sharon Saydah; Amy K Mottl; Dana Dabelea; Mary Helen Black; Elizabeth J Mayer-Davis; Catherine Pihoker
Journal:  Horm Res Paediatr       Date:  2017-05-29       Impact factor: 2.852

7.  The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.

Authors:  Sushmita Banerjee; Surupa Basu; Ananda Sen; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2017-07-19       Impact factor: 3.714

8.  Vitamin D in nephrotic syndrome remission: a case-control study.

Authors:  Sushmita Banerjee; Surupa Basu; Jayati Sengupta
Journal:  Pediatr Nephrol       Date:  2013-05-25       Impact factor: 3.714

9.  Biochemical bone markers in nephrotic children.

Authors:  Nese Karaaslan Biyikli; Sevinc Emre; Aydan Sirin; Ilmay Bilge
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

10.  Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort.

Authors:  Juhi Kumar; Kelly McDermott; Alison G Abraham; Lisa Aronson Friedman; Valerie L Johnson; Frederick J Kaskel; Susan L Furth; Bradley A Warady; Anthony A Portale; Michal L Melamed
Journal:  Pediatr Nephrol       Date:  2015-08-26       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.